Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy.
about
PEGylation of protein-based MRI contrast agents improves relaxivities and biocompatibilitiesImaging in breast cancer: magnetic resonance imaging.Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapyMeta-analysis of agreement between MRI and pathologic breast tumour size after neoadjuvant chemotherapyDesign of ProCAs (protein-based Gd(3+) MRI contrast agents) with high dose efficiency and capability for molecular imaging of cancer biomarkersDesign of a novel class of protein-based magnetic resonance imaging contrast agents for the molecular imaging of cancer biomarkersAgreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysisIn vivo breast sound-speed imaging with ultrasound tomography.Current and emerging quantitative magnetic resonance imaging methods for assessing and predicting the response of breast cancer to neoadjuvant therapy.Modern breast cancer detection: a technological reviewMRI for breast cancer: Current indicationsBreast imaging in the new eraCoregistration of dynamic contrast enhanced MRI and broadband diffuse optical spectroscopy for characterizing breast cancer.Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancerMagnetic resonance imaging features of breast cancer according to intrinsic subtypes: correlations with neoadjuvant chemotherapy effects.Magnetic resonance imaging for secondary assessment of breast density in a high-risk cohort.Classification of dynamic contrast-enhanced magnetic resonance breast lesions by support vector machines.MRI in breast cancer therapy monitoringNEO adjuvant chemotherapy in breast cancer: What have we learned so far?Prediction of pathological complete response of breast cancer patients undergoing neoadjuvant chemotherapy: usefulness of breast MRI computer-aided detectionBreast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast.Computer-aided evaluation of breast MRI for the residual tumor extent and response monitoring in breast cancer patients receiving neoadjuvant chemotherapyThe role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic reviewMRI enhancement in stromal tissue surrounding breast tumors: association with recurrence free survival following neoadjuvant chemotherapy.Quantification of background enhancement in breast magnetic resonance imagingNeoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging.Neoadjuvant chemotherapy for primary breast cancer: lessons learned and opportunities to optimize therapy.MR imaging of the breast: indications, established technique, and new directions.Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast, April 26-28, 2003, Philadelphia, Pennsylvania.High-resolution diffusion-weighted imaging for monitoring breast cancer treatment response.Optimized breast MRI functional tumor volume as a biomarker of recurrence-free survival following neoadjuvant chemotherapy.High-resolution diffusion-weighted magnetic resonance imaging in patients with locally advanced breast cancer.Effect of Imaging Parameter Thresholds on MRI Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes.Diagnostic performance of magnetic resonance imaging for assessing tumor response in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy is associated with molecular biomarker profile.The role of magnetic resonance imaging in diagnosis and management of breast cancer.Incorporating new imaging models in breast cancer management.Diffuse optical spectroscopy evaluation of treatment response in women with locally advanced breast cancer receiving neoadjuvant chemotherapyImaging breast cancer response during neoadjuvant systemic therapy.Comparison of mammography, sonography, MRI and clinical examination in patients with locally advanced or inflammatory breast cancer who underwent neoadjuvant chemotherapy.Advances in breast imaging: magnetic resonance imaging.
P2860
Q24594884-855BDADC-759C-43AC-BCB2-9BD5F80FD460Q24813813-3ED52F39-C889-4A88-BD00-1B8428300375Q27024544-6F688CA8-CF37-4C0F-B90E-AA49F47AD96DQ27027281-AB751ECE-4EEF-4ED4-B8F1-F1BA2ECD1E13Q28235682-0272D09D-451B-4349-8DB6-B1BD2170C1FEQ28283802-BE6D1E22-8DDC-4ECB-92B7-153273393BDCQ30401252-7AFD9897-176F-40C2-9134-8DDAE7CE21ADQ30443335-D95A013D-FB84-4E5D-A225-DDD09C0B4A25Q30460977-0890AA8F-EA2C-4C07-9F2A-4E5B1F27B7D1Q30484044-6C3757A5-2C64-41E4-B245-A7BDB6F7C78AQ30485242-974AEFA0-E242-4FE0-869D-AA0E5C12CD82Q30501446-3841F985-01B8-4347-863D-39E35B5589EEQ33223642-CD934DA2-C3CF-47FF-855C-03FD7E5670B7Q33620136-11A8C23D-C8BC-462C-952B-EEA6321D227AQ33690733-3871E986-B000-4288-B486-A89AB9AB6FF6Q33864841-05578BAE-5246-4725-B070-92D77C444A55Q33935862-80AA04E4-0D1B-42FE-A7E5-EACAD987E72BQ33938324-1BD366FC-EB31-4998-BEEC-A67F78586F61Q34138174-5192DB54-075E-4EFD-A45A-45835BD9136CQ34392087-4C60C86B-E369-42D3-B2EE-2305EA2062F3Q34436372-C858AE3C-AC79-4050-9DAF-C90557CFE7DAQ34475469-1806F41A-9D22-4861-984E-13A543EFDD98Q34566213-174C1284-2191-4156-B114-305DDC4BF983Q34716975-BCF0B39C-AFE1-4693-8858-ABE55FCD1DFBQ34837611-156E0372-AF77-42A3-8D75-3273E9544EE3Q34940150-AAECCF52-A149-4C32-8E94-D06501E483C7Q35688592-99442380-A728-4A68-9098-91715569FD91Q35688693-CA60C062-8434-4188-9223-88C62157237EQ35805644-472D9B45-4E84-44E6-9F9D-806B50A97E48Q35866592-40A96636-0566-4C8C-9C1B-6AFCEB37DADCQ35866905-4313D4D2-BB1B-49AD-B7FC-AB7C3FD12623Q35869462-3BD7BD0A-F059-419A-8FED-E7F87E9E072FQ35926256-1CB08858-1B0E-40A5-997E-3700B504EBB3Q35928203-15F130E1-D464-4600-AFBD-B2C89EA91212Q35961071-2CD37FF7-3645-4CA0-AB40-A157BE941F24Q36046248-7F9D4433-1F69-4571-8EDE-569AF1FA24A0Q36199832-A9B06940-F92D-4FF2-BCFC-6B95CF0919D9Q36284526-DD8E9209-D6A2-41F9-98B5-3F58F40C68DDQ36324120-E45FCBAE-5C91-41DF-B2F2-0E2245D4B81FQ36389872-C54C1308-FAB7-45C9-B88F-64385319B221
P2860
Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Accuracy of MR imaging for rev ...... gone neoadjuvant chemotherapy.
@en
Accuracy of MR imaging for rev ...... gone neoadjuvant chemotherapy.
@nl
type
label
Accuracy of MR imaging for rev ...... gone neoadjuvant chemotherapy.
@en
Accuracy of MR imaging for rev ...... gone neoadjuvant chemotherapy.
@nl
prefLabel
Accuracy of MR imaging for rev ...... gone neoadjuvant chemotherapy.
@en
Accuracy of MR imaging for rev ...... gone neoadjuvant chemotherapy.
@nl
P2093
P1476
Accuracy of MR imaging for rev ...... gone neoadjuvant chemotherapy.
@en
P2093
Dan Sudilovsky
Jessica E Gibbs
Laura J Esserman
Nola M Hylton
Savannah C Partridge
P304
P356
10.2214/AJR.179.5.1791193
P407
P577
2002-11-01T00:00:00Z